Copyright Reports & Markets. All rights reserved.

Global Disease Control and Prevention Vaccine Market Insights, Forecast to 2025

Request for Sample of this report
Buy now

Table of Contents

    1 Study Coverage

    • 1.1 Disease Control and Prevention Vaccine Product
    • 1.2 Market Segments
    • 1.3 Key Manufacturers Covered
    • 1.4 Market by Type
      • 1.4.1 Global Disease Control and Prevention Vaccine Market Size Growth Rate by Product
      • 1.4.2 Live-Attenuated
      • 1.4.3 Inactivated
      • 1.4.4 Recombinant Sub Unit and Toxoid
    • 1.5 Market by End User
      • 1.5.1 Global Disease Control and Prevention Vaccine Market Size Growth Rate by End User
      • 1.5.2 Pediatric Vaccine
      • 1.5.3 Adult Vaccine
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Executive Summary

    • 2.1 Global Disease Control and Prevention Vaccine Market Size
      • 2.1.1 Global Disease Control and Prevention Vaccine Revenue 2014-2025
      • 2.1.2 Global Disease Control and Prevention Vaccine Sales 2014-2025
    • 2.2 Disease Control and Prevention Vaccine Growth Rate by Regions
      • 2.2.1 Global Disease Control and Prevention Vaccine Sales by Regions
      • 2.2.2 Global Disease Control and Prevention Vaccine Revenue by Regions

    3 Breakdown Data by Manufacturers

    • 3.1 Disease Control and Prevention Vaccine Sales by Manufacturers
      • 3.1.1 Disease Control and Prevention Vaccine Sales by Manufacturers
      • 3.1.2 Disease Control and Prevention Vaccine Sales Market Share by Manufacturers
      • 3.1.3 Global Disease Control and Prevention Vaccine Market Concentration Ratio (CR5 and HHI)
    • 3.2 Disease Control and Prevention Vaccine Revenue by Manufacturers
      • 3.2.1 Disease Control and Prevention Vaccine Revenue by Manufacturers (2014-2019)
      • 3.2.2 Disease Control and Prevention Vaccine Revenue Share by Manufacturers (2014-2019)
    • 3.3 Disease Control and Prevention Vaccine Price by Manufacturers
    • 3.4 Disease Control and Prevention Vaccine Manufacturing Base Distribution, Product Types
      • 3.4.1 Disease Control and Prevention Vaccine Manufacturers Manufacturing Base Distribution, Headquarters
      • 3.4.2 Manufacturers Disease Control and Prevention Vaccine Product Type
      • 3.4.3 Date of International Manufacturers Enter into Disease Control and Prevention Vaccine Market
    • 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Product

    • 4.1 Global Disease Control and Prevention Vaccine Sales by Product
    • 4.2 Global Disease Control and Prevention Vaccine Revenue by Product
    • 4.3 Disease Control and Prevention Vaccine Price by Product

    5 Breakdown Data by End User

    • 5.1 Overview
    • 5.2 Global Disease Control and Prevention Vaccine Breakdown Data by End User

    6 North America

    • 6.1 North America Disease Control and Prevention Vaccine by Countries
      • 6.1.1 North America Disease Control and Prevention Vaccine Sales by Countries
      • 6.1.2 North America Disease Control and Prevention Vaccine Revenue by Countries
      • 6.1.3 United States
      • 6.1.4 Canada
      • 6.1.5 Mexico
    • 6.2 North America Disease Control and Prevention Vaccine by Product
    • 6.3 North America Disease Control and Prevention Vaccine by End User

    7 Europe

    • 7.1 Europe Disease Control and Prevention Vaccine by Countries
      • 7.1.1 Europe Disease Control and Prevention Vaccine Sales by Countries
      • 7.1.2 Europe Disease Control and Prevention Vaccine Revenue by Countries
      • 7.1.3 Germany
      • 7.1.4 France
      • 7.1.5 UK
      • 7.1.6 Italy
      • 7.1.7 Russia
    • 7.2 Europe Disease Control and Prevention Vaccine by Product
    • 7.3 Europe Disease Control and Prevention Vaccine by End User

    8 Asia Pacific

    • 8.1 Asia Pacific Disease Control and Prevention Vaccine by Countries
      • 8.1.1 Asia Pacific Disease Control and Prevention Vaccine Sales by Countries
      • 8.1.2 Asia Pacific Disease Control and Prevention Vaccine Revenue by Countries
      • 8.1.3 China
      • 8.1.4 Japan
      • 8.1.5 Korea
      • 8.1.6 India
      • 8.1.7 Australia
      • 8.1.8 Indonesia
      • 8.1.9 Malaysia
      • 8.1.10 Philippines
      • 8.1.11 Thailand
      • 8.1.12 Vietnam
      • 8.1.13 Singapore
    • 8.2 Asia Pacific Disease Control and Prevention Vaccine by Product
    • 8.3 Asia Pacific Disease Control and Prevention Vaccine by End User

    9 Central & South America

    • 9.1 Central & South America Disease Control and Prevention Vaccine by Countries
      • 9.1.1 Central & South America Disease Control and Prevention Vaccine Sales by Countries
      • 9.1.2 Central & South America Disease Control and Prevention Vaccine Revenue by Countries
      • 9.1.3 Brazil
    • 9.2 Central & South America Disease Control and Prevention Vaccine by Product
    • 9.3 Central & South America Disease Control and Prevention Vaccine by End User

    10 Middle East and Africa

    • 10.1 Middle East and Africa Disease Control and Prevention Vaccine by Countries
      • 10.1.1 Middle East and Africa Disease Control and Prevention Vaccine Sales by Countries
      • 10.1.2 Middle East and Africa Disease Control and Prevention Vaccine Revenue by Countries
      • 10.1.3 GCC Countries
      • 10.1.4 Turkey
      • 10.1.5 Egypt
      • 10.1.6 South Africa
    • 10.2 Middle East and Africa Disease Control and Prevention Vaccine by Product
    • 10.3 Middle East and Africa Disease Control and Prevention Vaccine by End User

    11 Company Profiles

    • 11.1 GSK
      • 11.1.1 GSK Company Details
      • 11.1.2 Company Business Overview
      • 11.1.3 GSK Disease Control and Prevention Vaccine Sales, Revenue and Gross Margin (2014-2019)
      • 11.1.4 GSK Disease Control and Prevention Vaccine Products Offered
      • 11.1.5 GSK Recent Development
    • 11.2 Merck & Co., Inc
      • 11.2.1 Merck & Co., Inc Company Details
      • 11.2.2 Company Business Overview
      • 11.2.3 Merck & Co., Inc Disease Control and Prevention Vaccine Sales, Revenue and Gross Margin (2014-2019)
      • 11.2.4 Merck & Co., Inc Disease Control and Prevention Vaccine Products Offered
      • 11.2.5 Merck & Co., Inc Recent Development
    • 11.3 Pfizer
      • 11.3.1 Pfizer Company Details
      • 11.3.2 Company Business Overview
      • 11.3.3 Pfizer Disease Control and Prevention Vaccine Sales, Revenue and Gross Margin (2014-2019)
      • 11.3.4 Pfizer Disease Control and Prevention Vaccine Products Offered
      • 11.3.5 Pfizer Recent Development
    • 11.4 Sanofi
      • 11.4.1 Sanofi Company Details
      • 11.4.2 Company Business Overview
      • 11.4.3 Sanofi Disease Control and Prevention Vaccine Sales, Revenue and Gross Margin (2014-2019)
      • 11.4.4 Sanofi Disease Control and Prevention Vaccine Products Offered
      • 11.4.5 Sanofi Recent Development
    • 11.5 AstraZeneca PLC
      • 11.5.1 AstraZeneca PLC Company Details
      • 11.5.2 Company Business Overview
      • 11.5.3 AstraZeneca PLC Disease Control and Prevention Vaccine Sales, Revenue and Gross Margin (2014-2019)
      • 11.5.4 AstraZeneca PLC Disease Control and Prevention Vaccine Products Offered
      • 11.5.5 AstraZeneca PLC Recent Development
    • 11.6 Sinovac Biotech Ltd
      • 11.6.1 Sinovac Biotech Ltd Company Details
      • 11.6.2 Company Business Overview
      • 11.6.3 Sinovac Biotech Ltd Disease Control and Prevention Vaccine Sales, Revenue and Gross Margin (2014-2019)
      • 11.6.4 Sinovac Biotech Ltd Disease Control and Prevention Vaccine Products Offered
      • 11.6.5 Sinovac Biotech Ltd Recent Development
    • 11.7 Astellas Pharma Inc
      • 11.7.1 Astellas Pharma Inc Company Details
      • 11.7.2 Company Business Overview
      • 11.7.3 Astellas Pharma Inc Disease Control and Prevention Vaccine Sales, Revenue and Gross Margin (2014-2019)
      • 11.7.4 Astellas Pharma Inc Disease Control and Prevention Vaccine Products Offered
      • 11.7.5 Astellas Pharma Inc Recent Development
    • 11.8 Serum Institute of India Pvt. Ltd
      • 11.8.1 Serum Institute of India Pvt. Ltd Company Details
      • 11.8.2 Company Business Overview
      • 11.8.3 Serum Institute of India Pvt. Ltd Disease Control and Prevention Vaccine Sales, Revenue and Gross Margin (2014-2019)
      • 11.8.4 Serum Institute of India Pvt. Ltd Disease Control and Prevention Vaccine Products Offered
      • 11.8.5 Serum Institute of India Pvt. Ltd Recent Development
    • 11.9 Daiichi Sankyo
      • 11.9.1 Daiichi Sankyo Company Details
      • 11.9.2 Company Business Overview
      • 11.9.3 Daiichi Sankyo Disease Control and Prevention Vaccine Sales, Revenue and Gross Margin (2014-2019)
      • 11.9.4 Daiichi Sankyo Disease Control and Prevention Vaccine Products Offered
      • 11.9.5 Daiichi Sankyo Recent Development

    12 Future Forecast

    • 12.1 Disease Control and Prevention Vaccine Market Forecast by Regions
      • 12.1.1 Global Disease Control and Prevention Vaccine Sales Forecast by Regions 2019-2025
      • 12.1.2 Global Disease Control and Prevention Vaccine Revenue Forecast by Regions 2019-2025
    • 12.2 Disease Control and Prevention Vaccine Market Forecast by Product
      • 12.2.1 Global Disease Control and Prevention Vaccine Sales Forecast by Product 2019-2025
      • 12.2.2 Global Disease Control and Prevention Vaccine Revenue Forecast by Product 2019-2025
    • 12.3 Disease Control and Prevention Vaccine Market Forecast by End User
    • 12.4 North America Disease Control and Prevention Vaccine Forecast
    • 12.5 Europe Disease Control and Prevention Vaccine Forecast
    • 12.6 Asia Pacific Disease Control and Prevention Vaccine Forecast
    • 12.7 Central & South America Disease Control and Prevention Vaccine Forecast
    • 12.8 Middle East and Africa Disease Control and Prevention Vaccine Forecast

    13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

    • 13.1 Market Opportunities and Drivers
    • 13.2 Market Challenges
    • 13.3 Market Risks/Restraints
    • 13.4 Macroscopic Indicators

    14 Value Chain and Sales Channels Analysis

    • 14.1 Value Chain Analysis
    • 14.2 Disease Control and Prevention Vaccine Customers
    • 14.3 Sales Channels Analysis
      • 14.3.1 Sales Channels
      • 14.3.2 Distributors

    15 Research Findings and Conclusion

      16 Appendix

      • 16.1 Research Methodology
        • 16.1.1 Methodology/Research Approach
        • 16.1.2 Data Source
      • 16.2 Author Details

      Vaccines are biological entity used to activate acquired immunity to control or prevent particular disease or a group of disease. Immunization is carried out in infants as well as in adults. Vaccination against various bacterial and viral diseases is an integral part of infectious disease control world-wide.
      The global Disease Control and Prevention Vaccine market is valued at 41100 million US$ in 2018 and will reach 102500 million US$ by the end of 2025, growing at a CAGR of 12.1% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Disease Control and Prevention Vaccine market based on company, product type, end user and key regions.

      This report studies the global market size of Disease Control and Prevention Vaccine in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Disease Control and Prevention Vaccine in these regions.
      This research report categorizes the global Disease Control and Prevention Vaccine market by top players/brands, region, type and end user. This report also studies the global Disease Control and Prevention Vaccine market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

      The following manufacturers are covered in this report, with sales, revenue, market share for each company:
      GSK
      Merck & Co., Inc
      Pfizer
      Sanofi
      AstraZeneca PLC
      Sinovac Biotech Ltd
      Astellas Pharma Inc
      Serum Institute of India Pvt. Ltd
      Daiichi Sankyo

      Market size by Product
      Live-Attenuated
      Inactivated
      Recombinant Sub Unit and Toxoid
      Market size by End User
      Pediatric Vaccine
      Adult Vaccine

      Market size by Region
      North America
      United States
      Canada
      Mexico
      Asia-Pacific
      China
      India
      Japan
      South Korea
      Australia
      Indonesia
      Singapore
      Malaysia
      Philippines
      Thailand
      Vietnam
      Europe
      Germany
      France
      UK
      Italy
      Spain
      Russia
      Central & South America
      Brazil
      Rest of Central & South America
      Middle East & Africa
      GCC Countries
      Turkey
      Egypt
      South Africa

      The study objectives of this report are:
      To study and analyze the global Disease Control and Prevention Vaccine market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
      To understand the structure of Disease Control and Prevention Vaccine market by identifying its various subsegments.
      To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
      Focuses on the key global Disease Control and Prevention Vaccine companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
      To project the value and sales volume of Disease Control and Prevention Vaccine submarkets, with respect to key regions.
      To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

      In this study, the years considered to estimate the market size of Disease Control and Prevention Vaccine are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025

      This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Disease Control and Prevention Vaccine market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

      For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

      Buy now